Belkacem Issad

1.1k total citations
42 papers, 660 citations indexed

About

Belkacem Issad is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Belkacem Issad has authored 42 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Belkacem Issad's work include Dialysis and Renal Disease Management (24 papers), Neurological and metabolic disorders (6 papers) and Central Venous Catheters and Hemodialysis (5 papers). Belkacem Issad is often cited by papers focused on Dialysis and Renal Disease Management (24 papers), Neurological and metabolic disorders (6 papers) and Central Venous Catheters and Hemodialysis (5 papers). Belkacem Issad collaborates with scholars based in France, United States and Belgium. Belkacem Issad's co-authors include Philippe Freida, M Legrain, Mahmoud Allouache, Jacques Rottembourg, José Luis Gallego Ortega, F Aimé, Patrice Degoulet, Pierre–Yves Durand, C Jacobs and Jacques Chanliau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Hypertension.

In The Last Decade

Belkacem Issad

38 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belkacem Issad France 16 485 194 158 92 63 42 660
Lesley Russell United Kingdom 6 542 1.1× 146 0.8× 170 1.1× 92 1.0× 60 1.0× 7 629
Lilia R. Lukowsky United States 12 560 1.2× 124 0.6× 139 0.9× 97 1.1× 88 1.4× 21 752
CA Jones United States 3 570 1.2× 115 0.6× 120 0.8× 64 0.7× 114 1.8× 9 759
Marjorie Foo Singapore 13 541 1.1× 153 0.8× 133 0.8× 92 1.0× 33 0.5× 24 652
Moniek W.M. van de Luijtgaarden Netherlands 11 583 1.2× 134 0.7× 116 0.7× 95 1.0× 37 0.6× 13 764
Janet Bryan United Kingdom 5 569 1.2× 179 0.9× 188 1.2× 106 1.2× 53 0.8× 5 656
Daljit K. Hothi United Kingdom 13 471 1.0× 165 0.9× 187 1.2× 89 1.0× 55 0.9× 32 775
W E Bloembergen United States 9 596 1.2× 241 1.2× 188 1.2× 100 1.1× 29 0.5× 10 818
Maarten A.M. Jansen Netherlands 8 745 1.5× 240 1.2× 219 1.4× 112 1.2× 52 0.8× 9 818
Raymond Vanholder Belgium 11 480 1.0× 114 0.6× 129 0.8× 70 0.8× 72 1.1× 17 625

Countries citing papers authored by Belkacem Issad

Since Specialization
Citations

This map shows the geographic impact of Belkacem Issad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belkacem Issad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belkacem Issad more than expected).

Fields of papers citing papers by Belkacem Issad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belkacem Issad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belkacem Issad. The network helps show where Belkacem Issad may publish in the future.

Co-authorship network of co-authors of Belkacem Issad

This figure shows the co-authorship network connecting the top 25 collaborators of Belkacem Issad. A scholar is included among the top collaborators of Belkacem Issad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belkacem Issad. Belkacem Issad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rostoker, Guy, et al.. (2025). Assisted peritoneal dialysis in France threatened by restrictive interpretation of legislation by CPAM?. SHILAP Revista de lepidopterología. 8(4). 295–298.
2.
Issad, Belkacem. (2021). Place de la dialyse péritonéale dans le monde et en France : aspects épidémiologiques et principales indications. Bulletin de l Académie Nationale de Médecine. 206(2). 200–214. 2 indexed citations
3.
4.
Rostoker, Guy, Christelle Loridon, Mireille Griuncelli, et al.. (2018). Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. EBioMedicine. 39. 461–471. 28 indexed citations
5.
Issad, Belkacem, et al.. (2017). Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis. Kidney International Reports. 2(6). 1219–1222. 10 indexed citations
6.
Servais, Aude, Lucile Mercadal, Florence Brossier, et al.. (2009). Rapid Curbing of a Vancomycin-Resistant Enterococcus faecium Outbreak in a Nephrology Department. Clinical Journal of the American Society of Nephrology. 4(10). 1559–1564. 17 indexed citations
7.
Freida, Philippe, et al.. (2008). The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis. Kidney International. 73(108). S102–S111. 16 indexed citations
8.
Issad, Belkacem, Éric Goffin, Jean‐Philippe Ryckelynck, & Christian Verger. (2008). L’accès péritonéal : le point de vue du néphrologue. Néphrologie & Thérapeutique. 4(4). 289–294. 3 indexed citations
9.
Pucheu, Sylvie, et al.. (2004). The Relationship of Quality of Life with the Severity of Disease and Non-Expression of Emotions in Peritoneal Dialysis. Peritoneal Dialysis International. 24(1). 77–79. 7 indexed citations
10.
Pucheu, Sylvie, et al.. (2004). Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients?. Journal of Psychosomatic Research. 56(3). 317–322. 50 indexed citations
11.
Emery, Corinne, et al.. (2003). [The EPO beta injection pen in patients in maintenance dialysis or predialysis: acceptability, satisfaction and cost assessment].. PubMed. 32(40). 1907–12. 1 indexed citations
12.
Bonnefont‐Rousselot, Dominique, M C Jaudon, Belkacem Issad, et al.. (1997). Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation. 12(7). 1399–1405. 40 indexed citations
13.
Issad, Belkacem, et al.. (1996). 213 Elderly Uremic Patients over 75 Years of Age Treated with Long Term Peritoneal Dialysis: A French Multicenter Study. Peritoneal Dialysis International. 16(1_suppl). 414–420. 33 indexed citations
14.
Freida, Philippe, et al.. (1996). How to Reach Optimal Creatinine Clearances in Automated Peritoneal Dial Ysis. Peritoneal Dialysis International. 16(2_suppl). 167–171. 9 indexed citations
15.
Issad, Belkacem, et al.. (1996). 213 Elderly Uremic Patients over 75 Years of age Treated with Long Term Peritoneal Dialysis: A French Multicenter Study. Peritoneal Dialysis International. 16(2_suppl). 414–420. 5 indexed citations
16.
Thillet, Joëlle, Claire Faucher, Belkacem Issad, et al.. (1993). Lipoprotein(a) in Patients Treated by Continuous Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases. 22(1). 226–232. 23 indexed citations
17.
Luzar, Mary Anne, et al.. (1990). Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.. PubMed. 10(1). 25–9. 70 indexed citations
18.
Rottembourg, J, Belkacem Issad, Mahmoud Allouache, & C Jacobs. (1989). Recovery of renal function in patients treated by CAPD.. PubMed. 5. 63–6. 17 indexed citations
19.
Rottembourg, Jacques, et al.. (1985). Continuous ambulatory peritoneal dialysis in diabetic patients. The relationship of hypertension to retinopathy and cardiovascular complications.. Hypertension. 7(6_pt_2). II125–30. 3 indexed citations
20.
Rottembourg, Jacques, Belkacem Issad, José Luis Gallego Ortega, et al.. (1983). Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.. PubMed. 19. 397–403. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lesley Russell Breakdown of academic impact, for papers by Lilia R. Lukowsky Breakdown of academic impact, for papers by CA Jones Breakdown of academic impact, for papers by Marjorie Foo Breakdown of academic impact, for papers by Moniek W.M. van de Luijtgaarden Breakdown of academic impact, for papers by Janet Bryan Breakdown of academic impact, for papers by Daljit K. Hothi Breakdown of academic impact, for papers by W E Bloembergen Breakdown of academic impact, for papers by Maarten A.M. Jansen Breakdown of academic impact, for papers by Raymond Vanholder
Rankless by CCL
2026